Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Heterogeneity among patients with latent autoimmune diabetes in adults.

Maruyama T, Nakagawa T, Kasuga A, Murata M.

Diabetes Metab Res Rev. 2011 Nov;27(8):971-4. doi: 10.1002/dmrr.1238.

PMID:
22069295
2.

Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.

Törn C, Landin-Olsson M, Ostman J, Scherstén B, Arnqvist H, Blohmé G, Björk E, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G, Lernmark A.

Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):442-47.

PMID:
11114103
3.

Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.

Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.

J Autoimmun. 1998 Dec;11(6):643-50.

PMID:
9878086
5.

Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.

Li X, Yang L, Zhou Z, Huang G, Yan X.

Chin Med J (Engl). 2003 Nov;116(11):1728-32.

PMID:
14642146
6.
7.

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R.

Lancet. 1997 Nov 1;350(9087):1288-93. Erratum in: Lancet 1998 Jan 31;351(9099):376.

PMID:
9357409
8.

[Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].

Calsolari MR, Rosário PW, Reis JS, Silva SC, Purisch S.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. Review. Portuguese.

9.
10.

[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].

Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.

Orv Hetil. 2001 Nov 18;142(46):2571-8. Hungarian.

PMID:
11770176
11.

Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization.

Rosário PW, Reis JS, Fagundes TA, Calsolari MR, Amim R, Silva SC, Purisch S.

Arq Bras Endocrinol Metabol. 2007 Feb;51(1):52-8.

12.

Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.

Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR.

Diabetologia. 2008 Aug;51(8):1368-74. doi: 10.1007/s00125-008-1052-6.

PMID:
18528678
13.

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

Diabetes Care. 2000 Jun;23(6):838-44.

14.
15.

High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.

Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W, Zhou Z.

Clin Endocrinol (Oxf). 2011 May;74(5):587-92. doi: 10.1111/j.1365-2265.2011.03976.x.

PMID:
21470281
16.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group..

Diabetes Care. 2008 Mar;31(3):534-8.

PMID:
18056891
17.

[Detection of antibodies against pancreatic islet cells in clinical practice].

Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.

Orv Hetil. 1999 Nov 28;140(48):2695-701. Hungarian.

PMID:
10645715
18.

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V, Bingley PJ, Levy JC, Mackay IR, Zimmet P, Holman RR, Clark A.

Diabetologia. 2007 Oct;50(10):2052-60.

PMID:
17657474
19.

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.

Dittler J, Seidel D, Schenker M, Ziegler AG.

Diabetes. 1998 Apr;47(4):592-7.

PMID:
9568692
20.

Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.

Kim CS, Nam JH, Nam JS, Park JS, Kang ES, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB.

Metabolism. 2006 Aug;55(8):1107-12.

PMID:
16839848
Items per page

Supplemental Content

Support Center